Recent News

• 03.12.2025 - Jefferies Biotech on the Beach Summit
• 03.11.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.10.2025 - Leerink 2025 Global Biopharma Conference
• 03.04.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 03.04.2025 - Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.27.2025 - Intellia Therapeutics Fourth Quarter and Full-Year 2024 Earnings Conference Call
• 02.27.2025 - Intellia Therapeutics Fourth Quarter and Full-Year 2024 Earnings Conference Call
• 02.27.2025 - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress
• 02.27.2025 - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress

Recent Filings

• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.27.2025 - 8-K Current report
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]